company background image
300702 logo

Zhejiang Tianyu Pharmaceutical XSEC:300702 Stock Report

Last Price

CN¥19.12

Market Cap

CN¥6.6b

7D

5.6%

1Y

-28.8%

Updated

05 May, 2024

Data

Company Financials +

Zhejiang Tianyu Pharmaceutical Co., Ltd.

XSEC:300702 Stock Report

Market Cap: CN¥6.6b

300702 Stock Overview

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally.

300702 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 300702 from our risk checks.

Zhejiang Tianyu Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Tianyu Pharmaceutical
Historical stock prices
Current Share PriceCN¥19.12
52 Week HighCN¥28.00
52 Week LowCN¥13.16
Beta-0.14
1 Month Change19.13%
3 Month Change34.55%
1 Year Change-28.79%
3 Year Change-48.66%
5 Year Changen/a
Change since IPO-36.98%

Recent News & Updates

Recent updates

Shareholder Returns

300702CN PharmaceuticalsCN Market
7D5.6%2.7%1.2%
1Y-28.8%-10.9%-12.6%

Return vs Industry: 300702 underperformed the CN Pharmaceuticals industry which returned -10.9% over the past year.

Return vs Market: 300702 underperformed the CN Market which returned -12.6% over the past year.

Price Volatility

Is 300702's price volatile compared to industry and market?
300702 volatility
300702 Average Weekly Movement6.0%
Pharmaceuticals Industry Average Movement7.1%
Market Average Movement8.3%
10% most volatile stocks in CN Market12.1%
10% least volatile stocks in CN Market5.0%

Stable Share Price: 300702's share price has been volatile over the past 3 months.

Volatility Over Time: 300702's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19935,070Yong Jun Tuwww.tianyupharm.com

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of cardiovascular, anti-diabetic, anti-atherosclerosis, anticoagulant, and anti-asthmatic series. It provides fine chemicals and CDMO services.

Zhejiang Tianyu Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhejiang Tianyu Pharmaceutical's earnings and revenue compare to its market cap?
300702 fundamental statistics
Market capCN¥6.58b
Earnings (TTM)-CN¥32.36m
Revenue (TTM)CN¥2.44b

2.7x

P/S Ratio

-203.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300702 income statement (TTM)
RevenueCN¥2.44b
Cost of RevenueCN¥1.51b
Gross ProfitCN¥932.43m
Other ExpensesCN¥964.79m
Earnings-CN¥32.36m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.094
Gross Margin38.22%
Net Profit Margin-1.33%
Debt/Equity Ratio48.2%

How did 300702 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.